RigImmune
United States · Founded 2020 · $3.5M raised
- Employees
- 1–10
- Founded
- 2020
- Website
- rigimmune.com
- Total Funding
- $3.5M
- Last Round
- $3.5M GrantJan 2023
- Rounds
- 2
About
Yale-spinout biopharmaceutical company developing RNA immunotherapies targeting the RIG-I innate immune pathway for viral diseases and cancer.
Summary
RigImmune is a Biotech company based in United States, founded in 2020. It has raised $3.5M in total across 2 rounds, most recently a $3.5M Grant round in Jan 2023. Investors include Bill & Melinda Gates Foundation and F-Prime Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...